Ibrahim A. Aljuffali
- Pharmaceutical Science top 0.5%
- Advancements in Transdermal Drug Delivery 28
- Dermatology top 0.5%
- Dermatology and Skin Diseases 12
- Skin Protection and Aging 9
- Dermatologic Treatments and Research 6
- Endocrinology top 5%
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 8
- Molecular Medicine top 5%
-
- Health Systems, Economic Evaluations, Quality of Life 8
- Pharmaceutical Economics and Policy 7
-
- Bee Products Chemical Analysis 6
- Co-authors
- Jia‐You FangChih-Hung LinShih-Chun YangCalvin T. SungChia-Lang FangChi‐Feng HungChwan‐Fwu LinTai‐Long Pan
- Journals
- Journal of Controlled Release (1 paper)International Journal of Pharmaceutics (4 papers)Pharmaceutical Research (5 papers)
- Partner nations
- Saudi ArabiaTaiwanUnited States
In The Last Decade
Ibrahim A. Aljuffali
80 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 143
- Pharmaceutical Science 620
- Dermatology 527
- Endocrinology 93
- Biomaterials 231
- Molecular Medicine 79
Countries citing papers authored by Ibrahim A. Aljuffali
This map shows the geographic impact of Ibrahim A. Aljuffali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim A. Aljuffali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim A. Aljuffali more than expected).
Fields of papers citing papers by Ibrahim A. Aljuffali
This network shows the impact of papers produced by Ibrahim A. Aljuffali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim A. Aljuffali. The network helps show where Ibrahim A. Aljuffali may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ibrahim A. Aljuffali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 4 | |
| 5 | 2020 | 11 | |
| 6 | 2017 | 6 | |
| 7 | 2017 | 24 | |
| 8 | 2017 | 11 | |
| 9 | 2016 | 35 | |
| 10 | 2015 | 34 | |
| 11 | 2015 | 17 | |
| 12 | 2015 | 28 | |
| 13 | 2015 | 31 | |
| 14 | 2015 | 12 | |
| 15 | 2014 | 12 | |
| 16 | 2014 | 8 | |
| 17 | 2014 | 9 | |
| 18 | 2013 | 25 | |
| 19 | 2013 | 66 | |
| 20 | 2012 | 49 |
About Ibrahim A. Aljuffali
Ibrahim A. Aljuffali is a scholar working on Pharmaceutical Science, Dermatology and Urology, having authored 82 papers that have together received 2.2k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (28 papers), Dermatology and Skin Diseases (12 papers), Skin Protection and Aging (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Nanoparticle-Based Drug Delivery (8 papers), Pharmaceutical Economics and Policy (7 papers), Bee Products Chemical Analysis (6 papers) and Dermatologic Treatments and Research (6 papers). The work is most often cited by research in Pharmaceutical Science (620 citations), Dermatology (527 citations) and Endocrinology (93 citations). Ibrahim A. Aljuffali has collaborated with scholars based in Saudi Arabia, Taiwan and United States. Frequent co-authors include Jia‐You Fang, Chih-Hung Lin, Shih-Chun Yang, Calvin T. Sung, Chia-Lang Fang, Chi‐Feng Hung, Chwan‐Fwu Lin, Tai‐Long Pan, Chi-Ting Huang and Pei‐Wen Wang. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.